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The intestine is populated with innate
lymphoid cells (ILCs) but how these cells
acquire tissue tropism is unclear. Kim and
colleagues show that group 1 ILCs (ILC1)
and ILC3 undergo retinoic-acid-
dependent upregulation of trafficking
receptors, whereas ILC2 acquire gut
homing receptors during development in
the bone marrow.
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Distinct groups of innate lymphoid cells (ILCs) such
as ILC1, ILC2, and ILC3 populate the intestine, but
how these ILCs develop tissue tropism for this or-
gan is unclear. We report that prior to migration to
the intestine ILCs first undergo a ‘‘switch’’ in their
expression of homing receptors from lymphoid to
gut homing receptors. This process is regulated
by mucosal dendritic cells and the gut-specific tis-
sue factor retinoic acid (RA). This change in homing
receptors is required for long-term population and
effector function of ILCs in the intestine. Only
ILC1 and ILC3, but not ILC2, undergo the RA-
dependent homing receptor switch in gut-associ-
ated lymphoid tissues. In contrast, ILC2 acquire
gut homing receptors in a largely RA-independent
manner during their development in the bone
marrow and can migrate directly to the intestine.
Thus, distinct programs regulate the migration of
ILC subsets to the intestine for regulation of innate
immunity.
INTRODUCTION
Innate lymphoid cells (ILCs) do not have antigen receptors but
produce effector cytokines in a manner reminiscent of T cells
(Spits et al., 2013; Tait Wojno and Artis, 2012; Walker et al.,
2013). ILCs play important roles in host defense against
pathogens and can mediate tissue inflammation. Three groups
of ILCs with distinct characteristics in development and effector
function have been identified. Group 1 ILCs (ILC1), including NK
cells, are induced by the transcription factor T-bet (Tbx21) and
produce interferon-g (IFN-g) (Bernink et al., 2013; Klose et al.,
2013; Powell et al., 2012; Sciume´ et al., 2012). ILC2,
which produce interleukin-5 (IL-5) and IL-13, require transcription
factors RORa, Gata3, and Tcf7 for development (Halim et al.,
2012; Hoyler et al., 2012; Klein Wolterink et al., 2013; Liang
et al., 2012; Mjo¨sberg et al., 2012; Mjo¨sberg et al., 2011; Moro
et al., 2010; Neill et al., 2010; Nussbaum et al., 2013; Price et al.,
2010; Yang et al., 2011). ILC3 require RORgt and Gata3 fordevelopment and are composed of IL-17- and IL-22-producing
lymphoid tissue-inducers, IL-17- IL-22- and IFN-g-producing
ILCs, and IL-22-producing natural cytotoxicity triggering receptor
(NCR)+ ILCs (Luci et al., 2009; Possot et al., 2011; Satoh-Ta-
kayama et al., 2008; Serafini et al., 2014; Sonnenberg et al.,
2011; Takatori et al., 2009; Vonarbourg et al., 2010). ILC3also pro-
duce GM-CSF for immune regulation (Mortha et al., 2014). The
importance of ILCs in mounting innate immunity and regulating
inflammatory responses in the intestine andothermucosal tissues
is now widely accepted.
Migration of lymphocytes is regulated by chemokines and in-
tegrins (Agace, 2008; Gorfu et al., 2009; Mora and von Andrian,
2008; Sheridan and Lefranc¸ois, 2011). Naive T cells utilize CCR7
and CD62L to migrate to secondary lymphoid tissues. Upon
antigen priming, T cells undergo homing receptor switches
in a tissue-specific manner. Gut-homing T cells downregulate
CCR7 and CD62L but upregulate the chemokine receptor
CCR9 and the integrin a4b7 (Iwata et al., 2004; Kang et al.,
2007). CCR9+a4b7+ cells migrate to the small intestine (SI), while
CCR9/dima4b7+ cells migrate into the colon. Acquisition of
these receptors occurs in gut-associated lymphoid tissues
such as mesenteric lymph node (MLN) and Peyer’s patches
(PP). CCL25, a chemokine expressed in the SI, activates CCR9
for adhesion triggering and chemotaxis (Kunkel et al., 2000;Wur-
bel et al., 2000; Zabel et al., 1999). a4b7 binds MAdCAM-1,
which is widely expressed on gut endothelial cells. It is generally
accepted that innate immune cells do not undergo such a so-
phisticated homing receptor switch for specific migration into a
tissue site. For example, NK cells, which arise in the bone
marrow (BM), upregulate inflammation-associated homing re-
ceptors to directly migrate to peripheral tissues (Morris and
Ley, 2004; Walzer and Vivier, 2011). It has been reported that
certain subsets of ILCs are characterized by their expression
of several trafficking receptors such as CCR6, CCR7, CCR9,
CXCR6, and/or a4b7 (Bouskra et al., 2008; Klose et al., 2013;
Possot et al., 2011; Satoh-Takayama et al., 2014). However,
how ILC subsets migrate and populate the intestine remains
largely unknown.
We report here that ILCs undergo homing receptor switches in
a shared yet subset-specific manner. ILC1 and ILC3 undergo a
homing receptor switch, which is regulated by retinoic acid
(RA) in the periphery, whereas ILC2 are developmentally pro-
grammed to upregulate gut homing receptors in BM and directly
migrate to the intestine. Hence, ILC have sophisticated andImmunity 43, 107–119, July 21, 2015 ª2015 Elsevier Inc. 107
Figure 1. Homing Receptor Expression by ILCs in Lymphoid and Intestinal Tissues
(A) Expression of CCR7, CCR9, and a4b7 by ILCs in secondary lymphoid tissues and the intestine. Total ILCs (LinCD90+CD127+) in the indicated organs and
intestinal lamina propria of C57BL/6 mice (n = 10) were examined for expression of CCR7, CCR9, and a4b7. Isotype (IgG2a/b) antibodies were used for negative
control staining.
(B) Expression of homing receptors by ILC subsets in the spleen, MLN, SI, and colon. Data from Rag1/ or C57BL/6 mice were essentially identical and
combined (n = 15). Gating strategies for ILC1 (LinCD127+CD90+EomesRORgtT-bet+), ILC2 (LinNK1.1CD127+CD90+Sca-1+KLRG-1+GATA-3+), and ILC3
(T-bet or T-bet+ LinCD127+CD90+RORgt+GATA-3) subsets are shown in Figure S1. The ‘‘Lin’’ antibody mixture refers to the ‘‘common lineage markers’’
described in the Experimental Procedures section. *Significant differences (p < 0.05) from spleen (A) or ILC2 (B). **The spleen T-bet+ ILC3 population was very
small (0.1% of LinCD127+CD90+ cells) and not shown. All error bars represent SEM.heterogeneous migration programs, which are important to
maintain the numbers and activities of different ILC subsets in
the gut.
RESULTS
ILCs Display Subset- and Tissue-Specific Expression of
Homing Receptors
Tissue-specific expression of homing receptors and their li-
gands is important for lymphocyte migration. To gain insights
into tissue-specific expression of homing receptors by ILCs,
we examined the expression of CCR7, CCR9, and a4b7 by T,
B, NK,myeloid, and other lineage-excluded (Lin) ILCs in various
tissues. CCR7 was highly expressed by the LinCD90+CD127+
ILCs in spleen and mesenteric lymph node (MLN), whereas
CCR9 was highly expressed by the ILCs in SI (Figure 1A).
Many CCR7+ ILCs were detected in lymphoid tissues such as
PP and colon. Many CCR9+ ILCs were detected in SI. MLN108 Immunity 43, 107–119, July 21, 2015 ª2015 Elsevier Inc.and colon also had some CCR9+ ILCs. a4b7 was highly ex-
pressed by both SI and colon ILCs. These data indicate that
ILCs express homing receptors in a tissue-specific manner.
Because ILCs are subdivided into ILC1, ILC2, and T-bet
or T-bet+ ILC3 populations, we also examined homing re-
ceptor expression by these subsets individually (Figure S1).
CCR7 is highly expressed by most T-bet ILC3 and many
T-bet+ ILC3 and ILC1 in MLN (Figure 1B). Many CCR7+ T-bet
ILC3 were found in MLN and spleen. Many CCR9+ T-bet ILC3
were found in SI and MLN. Many a4b7+ T-bet ILC3 were found
in the intestine. Overall, T-bet+ ILC3 were similar to T-bet ILC3
and ILC1 (Figure 1B). The expression of CCR7 by ILC2was low in
all of the organs. CCR9 expression was uniformly high on ILC2 of
all organs (Figure 1B). Significant numbers of ILC2 in spleen and
MLN but not in the intestine expressed a4b7. Thus, the ILC sub-
sets have similarities and differences in homing receptor expres-
sion. Similar results were observed in Rag1/ and WT C57BL/6
mice (not shown).
Homing-Receptor-Deficient Mice Have Abnormal
Numbers of ILC Subsets in a Receptor- and Tissue-
Specific Manner
Because ILCs expressed tissue and subset-dependent homing
receptors, we next examined the numbers and frequencies
of ILCs in lymphoid tissues and the intestine of distinct homing
receptor-deficient mice. ILC frequencies and numbers were
greatly decreased in the MLN of Ccr7/ mice (Figure 2A), as
well as in the SI and colon although to a lesser degree. ILC
numbers and frequencies were decreased specifically in the SI
of Ccr9/ mice (Figure 2A). ILCs were decreased in both the
SI and colon of Itgb7/mice. In contrast, ILCs were compensa-
torily increased in the lymphoid tissues of Ccr9/ or Itgb7/
mice (Figure 2A).
When ILC subsets were examined (Figures 2B and S2), a
clear difference was observed between the tissue distribution
of ILC2 and other ILC subsets. ILC2 were decreased in the SI
of Ccr9/ mice, but not in other homing receptors-
deficient mice analyzed. In contrast, ILC1 and ILC3 were
decreased in the MLN of Ccr7/ mice, SI of Ccr9/ mice,
and colon of Itgb7/ mice. ILC1 and ILC3 were somewhat
different from each other in their reliance on homing recep-
tors in that ILC3 numbers in the SI and colon were more
affected by Itg-b7 deficiency than their ILC1 counterparts.
Laser scanning confocal microscopy confirmed that CD90+
CD3 ILCs were reduced in frequency in the SI villi of
CCR9- or Itg-b7-deficient mice (Figure 2C). Many intraepithe-
lial ILC1 expressed CCR9 but few expressed a4b7 and CD103
(Figure S3A). In CCR9-deficient mice, ILC1 numbers were
moderately decreased in the intraepithelial compartment of
the SI, but not in the colon (Figure S3B). Taken together, the
results indicate that the three homing receptors analyzed var-
iably affect the normal population of ILC subsets in lymphoid
tissues or in the intestine.
RA InducesCCR9 and a4b7Expression on ILC1 and ILC3
But Does Not Alter ILC2 CCR9 Expression
Because RA is known to induce gut homing receptors in T cells
and B cells (Iwata et al., 2004; Kang et al., 2007; Mora et al.,
2006; Wang et al., 2010), we tested whether RA also induces
the expression of CCR9 and a4b7 in ILCs. Spleen Lin cells
were cultured with RA for 4 days before assessing homing re-
ceptor expression on ILCs. RA efficiently induced CCR9 and
a4b7 expression on ILCs while reducing CCR7 expression
(Figure 3A). Co-staining of CCR7 and gut homing receptors re-
vealed that RA induces a switch from CCR7+ CCR9 a4b7 to
CCR7 CCR9+ and/or a4b7+ expression in CD90+CD127+ ILCs
(Figure 3B). Because the composition of ILC subsets changes
after exposure to RA (Spencer et al., 2014), the induction of gut
homing receptors by RA was also examined on individual ILC
subsets. Induction of gut homing receptors was detected on
ILC1 and ILC3, but not on ILC2 in response to RA (Figure 3C).
The transcription factors RARa, RARb, and RARg are ex-
pressed by ILCs (Mielke et al., 2013). In our study, RARa
was most highly expressed by ILCs (data not shown).
AM580, an RARa agonist, had clear effects on inducing gut
homing receptors in ILC3 (Figure 3D) and ILC1 (data not
shown). LE540 (a pan-RAR antagonist) and Ro41-5253 (an
RARa antagonist) further decreased the basal expressionlevels of CCR9 and a4b7 on cultured ILC3 (Figure 3D) and
ILC1 (data not shown). Consistent with CCR9 expression, the
chemotactic response of ILC3 and ILC1 to the CCR9 ligand
CCL25 was increased after culture with RA, but was sup-
pressed by Ro41-5253 to the Ccr9/ level (Figure 3E). ILC2
migrated to CCL25 efficiently, and this was not further regu-
lated by exogenous RA or Ro41-5253. Overall, the homing re-
ceptor expression and chemotactic responses of ILC subsets
indicate there is a clear difference between ILC1, ILC3, and
ILC2.
A major cell source of RA in the intestine is dendritic cells
(DCs) (Coombes et al., 2007; Iwata et al., 2004). DCs express
retinal aldehyde dehydrogenases (RALDHs), which convert
retinaldehyde to RA. We compared the activity of MLN and
spleen DCs in regulating the homing receptor switch in ILCs.
MLN DCs were more efficient than splenic DCs in downre-
gulating CCR7 and upregulating CCR9 and a4b7 on ILC3 and
ILC1 (Figure 4A,B). The RARa antagonist Ro41-5253 blocked
the CCR7/CCR9 and a4b7 switch induced by MLN DCs,
suggesting a role for RARa (Figure 4A). Moreover, DEAB (an
RALDH inhibitor that blocks de novo production of RA from
retinaldehyde) effectively suppressed the switch in ILC3 (Fig-
ure 4A) and ILC1 (Figure 4B). These results indicate that the
RA derived from mucosal DCs can induce the homing receptor
switch in ILC3 and ILC1.
Vitamin A Deficiency Leads to Gut Homing-Receptor
Deficiency in ILC1 and ILC3, but Not ILC2
The positive role of RA in regulating the gut homing-receptor
expression in ILCs prompted us to examine the homing recep-
tor phenotype of ILCs in vitamin A-deficient (VAD) Rag1/
mice. These mice were generated by feeding mice with VAD
or normal (VAN) diet containing a standard level (2,500 IU/Kg)
of retinol for 11–12 weeks. ILC3 and ILC1 in the SI of VAD
mice had decreased levels of CCR9 and a4b7 expression.
However, their expression of CCR7 was somewhat increased
compared to their counterparts in VAN mice (Figure 4C). In
contrast, the homing-receptor phenotype of ILC2 was unaf-
fected by vitamin A deficiency (Figure 4C). In addition to gut
homing receptors, total ILC numbers were decreased by 2–3
times in the SI and colon of VAD mice (data not shown). Our
confocal imaging analysis revealed that ILCs numbers were
reduced in the intestinal lamina propria of VAD Rag1/ mice
(Figure 4D).
BM ILC2Progenitors ExpressGutHomingReceptors in a
RA-IndependentManner andCanDirectlyMigrate to the
Intestine
It has been reported that ILC2 progenitors (ILC2Ps) express gut
homing receptors (Hoyler et al., 2012). To ask whether expres-
sion of gut homing receptor by ILC2P in BM requires vitamin A
metabolites, we examined gut homing receptor expression by
ILC2P in the BM of VAD mice. Gut homing-receptor expression
by BM ILC2P was not affected in VADmice (Figure 5A), suggest-
ing that the gut homing receptors of ILC2P are not regulated by
vitamin A, unlike ILC3 and ILC1. We transferred BM cells into
CD45.1 congenic mice for a short-termmigration assay to deter-
mine whether these LinCD127+Sca-1hiCD25+KLRG-1 ILC2P
and related KLRG-1+ cells (Figure S4A) can migrate to theImmunity 43, 107–119, July 21, 2015 ª2015 Elsevier Inc. 109
Figure 2. CCR7, CCR9, and Itg-b7 Are Required for Normal Numbers of ILCs in a Tissue-Specific Manner
(A) Frequencies of LinCD90+CD127+ total ILCs in lymphoid tissues and the intestine of WT, Ccr7/, Ccr9/, or Itgb7/ mice.
(B) Frequencies of ILC subsets (ILC1, ILC2, and ILC3) in lymphoid tissues and the intestine of WT,Ccr7/,Ccr9/, or Itgb7/mice. (C) CD3CD90+ ILCs in the
SI of WT,Ccr9/, or Itgb7/mice were imaged by laser scanning confocal microscopy. Average numbers of CD3CD90+ ILCs per villus and section are shown
in the graph. The dot plots are shown for the Lin cell gate, and the graphs are relative numbers of ILCs in Ccr7/, Ccr9/, or Itgb7/mice compared to WT
mice (% of WT mice). The ‘‘Lin’’ mixture refers to the ‘‘common lineage markers.’’ Pooled data obtained from at least three different experiments (n = 15) are
shown. *Significant differences (p < 0.05) from WT. All error bars represent SEM.
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Figure 3. RA Promotes Loss of CCR7 but Gain of CCR9 and a4b7 Expression in ILC3 and ILC1 but Not ILC2
(A) Induction of gut homing receptors and downregulation of CCR7 on ILCs by RA. Expression of homing receptors on LinCD90+CD127+ ILCs was assessed
after the culture of spleen Lin cells for 4 days with RA or Ro41-5253 (an RARa antagonist).
(B) Induction of a homing receptor switch from CCR7 to CCR9 and a4b7 in cultured ILCs by RA.
(C) Impact of RA and Ro41-5253 on homing receptor expression by ILC subsets.
(D) Impact of RAR agonists and antagonists on homing receptor expression by ILC3 in vitro.
(E) Chemotaxis of control, RA, or Ro41-5253-treated ILC subsets to CCL25. Spleen Lin (or sorted ILC3 for panel C) cells were cultured with cecal bacterial
extract, IL-7, and IL-15 for ILC1; IL-7 for ILC2; cecal bacterial extract, IL-7, and IL-23 for ILC3. The ‘‘Lin’’ mixture refers to the ‘‘common lineage markers.’’ Pooled
data obtained from at least three different experiments are shown. *Significant differences (p < 0.05) from controls. All error bars represent SEM.intestine. Forty four hr after transfer, 20% of the BM KLRG-1
ILC2P and 30% of KLRG-1+ ILC2 lineage cells were found in
the SI and other tissues of the host mice among the tissuesexamined (Figures 5B and S4B), indicating that BM ILC2 progen-
itors can migrate to the intestine. They also migrated to MLN and
colon but less efficiently to lungs. No significant migration toImmunity 43, 107–119, July 21, 2015 ª2015 Elsevier Inc. 111
Figure 4. Mucosal DCs and Vitamin A Status Regulate the Expression of Homing Receptors by ILC3 and ILC1
(A) Mucosal DCs induce the homing receptor switch in ILC3.
(B) Mucosal DCs induce the homing receptor switch in ILC1. CD11c+ DCs, freshly isolated from spleen or MLN, and spleen Lin cells were co-cultured
(ratio = 1:10, 4 days) for 4 days in the presence of Ro41-5253 or DEAB (an RALDH inhibitor) in the culture conditions described in Figure 3. Ro41-5253 or DEAB
was added as indicated.
(legend continued on next page)
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Figure 5. BM ILC2P Can Directly Migrate to
the Intestine and Their Expression of Gut
Homing Receptors Is Not Affected by
Vitamin A Status
(A) Expression of CCR9 and a4b7 by BM ILC2P
(LinCD127+Sca-1hiCD25+KLRG-1) and more
mature ILC2 lineage cells (LinCD127+Sca-1hi
CD25+KLRG-1+) in VAN and VAD mice.
(B) Tissue distribution of BMKLRG-1- and KLRG-1+
ILC2 lineage cells 44 hr after cell transfer (i.v.).
(C) In vivo migration of WT versus homing recep-
tor-deficient BM ILC2 lineage cells. Lin Ly-6B.2
BM cells were injected i.v. into host mice and
sacrificed 44 hr later in (B) and (C). The ‘‘Lin’’
mixture refers to the ‘‘BM lineage markers.’’ *Sig-
nificant differences (p < 0.05) from WT. Pooled
data obtained from 3–7 different experiments (n =
3–10) are shown. All error bars represent SEM.adipose tissues was detected. CCR9 was required for migration
of BM KLRG-1 and KLRG-1+ ILC2 linage cells to the SI (Figures
5C and S4C). Migration of Itg-b7-deficient ILC2P and ILC2 to
MLN, SI and colon was reduced compared to that of WT cells.
These results indicate that optimal ILC2migration to the intestine
requires gut homing receptors, and this is programmed in BM
rather than regulated by vitamin A status.
The RA-Induced Homing Receptor Switch Is Required
for ILC3 Migration to the Intestine
We next asked whether CCR9 and a4b7, induced by RA, play
a role in ILC3 migration to the intestine. CD45.2+ CD90.1+
RA-ILC3 and CD45.2+ CD90.2+ control ILC3 were prepared by
culturing spleen Lin cells in an ILC3-promoting condition with
or without RA. These cells were co-injected intravenously (i.v.)(C) Expression of homing receptors by ILC subsets in the SI of VAN and VAD mice. Mice were fed with v
11–12 weeks before the examination of the ILC subsets.
(D) Confocal imaging of ILCs in SI of VAN and VADRag1/mice. Average numbers of CD90+ ILCs per each vi
obtained from at least three different experiments (n = 3 for A,B; n = 8–12 for C; n = 12 for D) are shown. *Sign
error bars represent SEM.
Immunity 43, 107–into CD45.1+ CD90.2+ mice for a 20 hr
homing assay (Figure 6A). The RA-
treated ILC3 (RA-ILC3) were highly effi-
cient in migrating to SI and colon, while
their numbers were decreased in the
blood (Figure 6A).
To more directly assess the role of
homing receptors, we prepared Ccr7/,
Ccr9/, and Itgb7/ ILC3-enriched cells
by culture with RA (WT, Ccr9/, and
Itgb7/ RA-ILC3) or without RA (WT
and Ccr7/ ILC3) and assessed for their
short-term (20 hr) migratory behavior
in vivo. Ccr9/ RA-ILC3 were unable to
efficiently migrate to SI (Figures 6B and
S5). The migration of Itgb7/ RA-ILC3
to both SI and colon was defective.
Ccr7/ ILC3 were less efficient than their
WT counterparts inmigration toMLN (Fig-ures 6B and S5). The numbers of remaining homing receptor-
deficient ILC3 in the blood and/or spleen were compensatorily
increased (Figure 6B), which is consistent with their defective
migration to MLN or intestine.
Homing Receptors Are Required for Long-Term
Population of ILC Subsets in Secondary Lymphoid
Tissues and the Intestine after BM Transplantation
To further examine the specific roles of homing receptors in
long-term population of ILCs in lymphoid tissues and intestine,
we transplanted mixed BM cells fromWT and homing receptor-
deficient mice into lethally irradiated CD45.1 mice, and the
numbers of ILC subsets in lymphoid tissues and the intestine
were examined 8 weeks later. Ccr7/ ILC3 were inefficient in
populating MLN (Figures 6C and S6). Ccr9/ ILC3 failed toitamin A-deficient (VAD) or normal (VAN) diets for
llus and section are shown in the graph. Pooled data
ificant differences (p < 0.05) from control or VAN. All
119, July 21, 2015 ª2015 Elsevier Inc. 113
Figure 6. RA-Induced CCR9 and Itg-b7 Are Required for Short-Term Migration of ILC3 and Long-Term Population of ILC Subsets in the
Intestine
(A) Short-term (20 hr) homing of control versus RA-treated ILC3 to the intestine and secondary LT.
(B) Short-term homing of WT versus homing receptor-deficient ILC3. Spleen cells, depleted of cells expressing the ‘‘splenocyte depletion markers’’ mentioned in
the Experimental Procedures section, were cultured for 4 days in an ILC3 culture condition (commensal bacteria extract, IL-7, and IL-23) for 4 days. The cells,
except Ccr7/ and matching WT cells, were treated with RA for the homing experiment.
(C) Impact of homing receptors on long-term population of ILC3, ILC1, and ILC2. A long-term competitive population study of WT and homing receptor-deficient
ILC subsets following mixed (1:1) BM transfer from CD45.2+CD90.1+ WT and CD45.2+CD90.2+ homing receptor-deficient mice. The ILC subsets were examined
in the indicated organs 8 weeks after the mixed BM transfer. Pooled data obtained from 2–3 different experiments (n = 7–10) are shown. *Significant differences
(p < 0.05) from control or between WT and homing receptor-deficient ILCs. All error bars represent SEM.normally populate the SI. Itgb7/ ILC3 failed to normally popu-
late both SI and colon (Figures 6C and S6). The tissue popu-
lation of ILC1 was similarly affected by homing-receptor defi-
ciency albeit at a reduced level compared to that of ILC3.
CCR9 deficiency decreased ILC2 population in SI, and Itg-b7
deficiency slightly decreased ILC2 population in the colon
but not SI. CCR7 deficiency did not have any influence on the
population of ILC2 in any tissues (Figure 6C). These results
reveal the distinct roles of homing receptors in determining
the tissue-specific population of ILC subsets in the intestine
and lymphoid tissues.114 Immunity 43, 107–119, July 21, 2015 ª2015 Elsevier Inc.ILC3 with Their Homing Receptors Switched by RA Can
Effectively Restore Defective Mucosal Immunity in
Vitamin A-Deficient Hosts
As reported recently (Spencer et al., 2014), VAD Rag1/ mice
are more susceptible to C. rodentium infection than VAN
Rag1/ mice and are deficient in ILC3 in the intestine (data
not shown). We tested whether ILC3, isolated from the spleen
and cultured in the presence of RA to induce gut homing recep-
tors, can restore themucosal immune deficiency in VADRag1/
mice, and whether the homing receptors play any role in this pro-
cess. First, we compared the ability of control and RA-treated
Figure 7. Gut Homing Receptors Are Required for Optimal ILC3 Effector Function during C. rodentium Infection
(A) Protective effects of control andRA ILC3 inC. rodentium-infected VADmice. Purified ILCs (Lin–NK1.1–KLRG-1–CD90hi), isolated fromWT,Ccr9/, or Itgb7/
mice, were cultured with RA (10 nM) in an ILC3 culture condition (commensal bacteria extract, IL-7, and IL-23) for 4 days for the cell transfer. Control- and RA-
treated ILC3 were transferred into VAD mice and infected with C. rodentium. Weight change and C. rodentium load were monitored.
(B) Protective effects of WT versus gut homing receptor-deficient RA-ILCs on C. rodentium infection. Weight change, pathogen burden, and stool scores were
determined.
(C) Tissue distribution of Lin–CD90+CD127+RORgt+ ILC3 and (D) expression of ILC3 cytokines and antimicrobial peptides following adoptive transfer of WT or gut
homing receptor-deficient ILC3 in VAD mice infected with C. rodentium. qRT-PCR was performed for panel D. The ‘‘Lin’’ mixture refers to the ‘‘splenocyte
depletion markers.’’ Pooled data obtained from two different experiments (n = 7–8) are shown. *Significant differences between VAN and VAD or from the control
(none) groups. All error bars represent SEM.ILC3 to protect VAD Rag1/ mice from C. rodentium infection
(Figure 7A). Only RA-treated ILC3 were effective in protecting
VAD Rag1/ mice. This could be due to the reported property
of RA in inducing ILC3 expansion and IL-22 expression (Mielke
et al., 2013; Spencer et al., 2014) rather than its effect on ILC3
migration. To sort out this issue, we performed the transfer of
WT versus Ccr9/ or Itgb7/ ILC3 into VAD mice. The weight
change and stool scores following C. rodentium infection indi-cate that both Ccr9/ and Itgb7/ ILC3 were less effective in
protecting VAD Rag1/ mice and clearing C. rodentium (Fig-
ure 7B). Ccr9/ and Itgb7/ ILC3 were less efficient than their
WT counterparts in populating the SI (Ccr9/) or the whole in-
testine (Itgb7/) of infected VAD Rag1/ mice (Figures 7C
and S7). A compensatory increase in ILC3 was observed in
the spleen and MLN (Figure 7C). The transfer of WT RA-ILC3
restored the defective mRNA expression of cytokines (Il17aImmunity 43, 107–119, July 21, 2015 ª2015 Elsevier Inc. 115
and Il22) and anti-microbial peptides (RegIIIb and RegIIIy) in the
intestine of VAD Rag1/ mice (Figure 7D). In general, Ccr9/
RA-ILC3were less efficient thanWT ILC3 in restoring the expres-
sion of these factors in SI, and Itgb7/ RA-ILC3 were defective
in inducing the factors in both SI and colon. Taken together,
these results indicate the importance of the homing receptor
switch regulated by RA for the effector function of ILC3 in the
gut. All indicators such as weight change, stool scores, and
pathogen burden following the infection indicate that Itg-b7 defi-
ciency had a greater effect than CCR9 deficiency on ILC3
effector function. This might be because CCR9 does not signifi-
cantly affect ILC3 migration to the colon, which is the major site
of infection by C. rodentium.
DISCUSSION
We found that ILC subsets actively migrate to the gut and
lymphoid tissues, and homing receptors are differentially
required for this process. We also observed that ILC1, ILC2,
and ILC3 are different from each other in homing receptor
expression and in vivo migration behavior. There exists a clear
dichotomy in the migration of ILC2 versus ILC1 and ILC3 to the
intestine. RA and vitamin A induce a homing receptor switch
for the migration of ILC3 and ILC1 to the gut but ILC2 migration
to the gut is not regulated byRA. The gut-homing ability of ILC2 is
developmentally programmed in BM rather than induced in the
periphery. Beyond the homeostatic migration of ILC subsets,
gut homing receptors are required to mount a normal ILC3
response to infection.
It has been unclear whether ILCs can specifically migrate to
the intestine utilizing homing receptors. We demonstrated that
ILCs can migrate into the intestine utilizing the two homing
receptors, CCR9 and a4b7, which are also utilized by other im-
mune cells such as T andB cells. a4b7 acts as an adhesionmole-
cule to bind MAdCAM-1, which is widely expressed on intestinal
endothelial cells in SI and colon. We found that ILC3 and ILC1 in
both SI and colon highly express a4b7 and require a4b7 to
migrate into the intestine. CCR9 is activated by the chemokine
CCL25, which is specifically expressed in SI. Indeed, SI ILCs
most highly express CCR9, and all ILC subsets require CCR9
to migrate into SI. 30%–50% of ILC1 and ILC3 in MLN also ex-
press CCR9 and a4b7, but these homing receptors are not
required for ILC migration into MLN. This implies that MLN is
more a generating site than a destination for CCR9+ a4b7+
ILCs. Thus, CCR9 is the SI-specific homing receptor, whereas
a4b7 is the pan-gut homing receptor required for migration of
ILC3 and ILC1.
CCR7 is highly expressed by the majority of ILC3 and ILC1 in
MLN. It is also expressed by 60% T-bet ILC3, but not many
T-bet+ ILC3 and ILC1 in the spleen. The CCR7 expression by
ILC3 and ILC1 is required for efficient migration of these ILCs to
MLN, but not to spleen. A recent report indicates that CCR7plays
a role in ILC3 recruitment from the intestine to MLN (Mackley
et al., 2015), which together our results indicate that ILC3 can
migrate in both ways between theMLN and intestine. Homing re-
ceptor-deficient ILCsareoftenenriched in the spleen, suggesting
that ILC migration to the spleen is probably a passive process
and does not involve specific homing receptors. Overall, our
data indicate that ILC3 and ILC1 undergo the homing receptor116 Immunity 43, 107–119, July 21, 2015 ª2015 Elsevier Inc.switch to change their tissue tropism. Dendritic cells in gut-
lymphoid tissues such as MLN produce RA and upregulate gut
homing receptors in ILC3 and ILC1. Thus, certain ILC subsets,
such as ILC3 and ILC1, canmigrate fromone organ to another af-
ter the homing receptor switch from CCR7 to CCR9 and a4b7,
which is typically conserved among antigen receptor-expressing
lymphocytes.We demonstrated that RA is a key factor in upregu-
lating the expression of both CCR9 and a4b7 on ILC1 and ILC3.
RA activates RARa, which functions to induce the transcription
of CCR9 and Itg-a4 genes (Iwata et al., 2004; Kang et al., 2011).
The fact that pan-RAR or RARa antagonists downregulate the
expression of CCR9 and a4b7 on ILCs supports the idea that
ILCs utilize RARs, particularly RARa, for upregulating gut homing
receptors and downregulating CCR7.
A question of interest is whether all ILC subsets undergo the
homing receptor switch induced by RA. ILC subsets are differen-
tially regulated by RA. RA suppresses ILC2 but increases ILC3
numbers and IL-22 expression (Mielke et al., 2013; Spencer
et al., 2014).We found a similar heterogeneity in homing receptor
expression. ILC3 were most sensitive to RA in the homing recep-
tor switch fromCCR7 toCCR9 and a4b7. ILC1 also responded to
RA in the homing receptor switch, but ILC2 did not respond to
RA. A rather unexpected observation is that ILC2 express
CCR9 in all of the organs that we examined, including spleen,
and that even immature BM ILC2P express gut homing receptors
(Hoyler et al., 2012). Unlike intestinal ILC3 and ILC1 and their BM
counterparts, intestinal ILC2 do not highly express a4b7. A clear
difference between ILC2 and ILC1/3 is the site of gut homing-re-
ceptor upregulation. This appears to occur in the periphery for
ILC1/3 based on their tissue-specific homing receptor profiles.
However, the gut homing receptor upregulation for ILC2 occurs
in BM. We observed that significant numbers of BM ILC2P
(20%) and ILC2 (30%) can migrate to SI within 44 hr after
cell transfer. Itg-b7 appears to play a role in BM ILC2 migration
not only to the intestine but also to MLN, but its function in the
long-term population of ILC2 was detected only in the colon.
This might be because other trafficking receptors might replace
a4b7 in the MLN and small intestine. CCR9 is important for both
the migration and population of ILC2 specifically in SI. Overall,
the gut-homing machinery of ILC2 is primarily developed early
in their development in BM rather than during their maturation
in the periphery.
Vitamin A status is a key factor in shifting the ILC distribution in
the body. ILC deficiency in the intestine is translated into defi-
cient expression of anti-microbial peptides and IL-22, leading
to defective mucosal immunity. In this regard, the decreased im-
munity to C. rodentium infection in VAD mice is, in part, due to
reduced numbers of ILC3 in the intestine. We demonstrated
that the homing behavior of ILC3 can be re-programmed by
RA. Importantly, without the normal expression of gut homing re-
ceptors, RA-treated ILC3 were not able to migrate and provide
effective immunity to fight pathogens. This underlies the impor-
tance of the migration ability of ILCs in determining their effector
function. A recent report indicates that CXCR6 plays a role in
maintaining a subset of ILC3 in SI lamina propria (Satoh-Ta-
kayama et al., 2014). It is likely that additional trafficking recep-
tors, regulated by non-RA signals, might be involved in the
recruitment of ILC subsets to specialized sites in the gut at
various stages of immune responses.
Our results provide novel insights into the migration programs
of major ILC subsets. ILC1 and ILC3 can reprogram their homing
receptor expression to migrate into the intestine in lymphoid
tissues, a process regulated by RA. This indicates that ILC3
and ILC1 possess sophisticated migration programs that are
similar to T and B cells. In contrast, the migration behavior of
ILC2 is tied to their development in BM rather than it is acquired
through the homing receptor switch in the periphery. In sum, our
findings point out that ILC subsets differentially utilize the migra-
tion programs of both innate and adaptive immune cells.
EXPERIMENTAL PROCEDURES
Animals
All animal experiments in this study were approved by the Purdue Animal Care
and Use Committee. C57BL/6 mice were from Harlan. CD45.1 congenic
(B6.SJL-Ptprca Pepcb/BoyJ, Stock# 002014), CD90.1 congenic (B6.PL-
Thy1a/CyJ, Stock# 000406), Rag1/ (B6.129s7-Rag1tm1Mom/J, Stock#
002216), Ccr7/ (B6.129P2(C)-Ccr7tm1Rfor/J, Stock# 006621), and Itgb7/
(C57BL/6-Itgb7tm1Cgn/J, Stock# 002965) mice were originally from the Jack-
son Laboratory. Ccr9/ mice in the C57BL/6 background were described
previously (Uehara et al., 2002). All strains were kept at Purdue for at least
12months. VAD and VANRag1/ or C57BL/6micewere prepared by keeping
mice on custom research diets (0 and 2,500 IU/kg of retinyl acetate respec-
tively for VAD and VAN, Harlan Teklad diets) immediately following birth and
after weaning until they are 11–12 weeks of age.
Characterization of ILC Subsets and Marrow Progenitors By Flow
Cytometry
Cells from intestinal lamina propria, PP, spleen, MLN, and blood were pre-
pared as previously described (Kang et al., 2007). For ILC1 and ILC3, cells
were first stained with antibodies to following the common lineage markers:
CD3ε (clone 145-2C11), CD5 (53-7.3), CD8a (53-6.7), CD19 (6D5), B220
(RA3-6B2), CD11b (M1/70), CD11c (N418), Ter119 (Ter-119), F4/80 (BM8),
Gr-1 (RB6-8C5), TCRb (H57-597), TCRgd (GL3), CD49b (DX5), and FcεR1a
(MAR-1) and other antigens (CD45.2/104, CD90.2/53-2.1, CD90.1/OX-7,
and/or CD127/A7R34), and then fixed and permeabilized for further staining
for intracellular antigens (T-bet/eBio-4B10, GATA-3/TWAJ, RORgt/AFKJS-9,
and/or Eomes/Dan11mag). For ILC2, cells were stained with antibodies to
the common lineage markers mentioned above and NK1.1/PK136, CD90.2,
CD90.1, CD127, Sca-1/D7, KLRG-1/2F1, and GATA-3. Intraepithelial cells,
extracted with HBSS (20 mM EDTA) followed by density-gradient centrifuga-
tion on 44%-percoll gradient, were stained with antibodies to the common
lineage markers, NKp46/29A1.4, and NK1.1. Most of the antibodies were
from BioLegend or eBioscience unless indicated otherwise. Gating strategies
for ILC subsets are described in Figure S1. BM cells were isolated from
femurs and tibias of Rag1/ or WT and homing receptor-deficient mice.
BM cells were stained with antibodies to CD127, Sca-1, CD25, KLRG-1,
and BM lineage markers (CD3ε, CD5, CD8a, B220, CD11b, Gr-1, Ter-119,
TCRgd, and NK1.1). BM ILC2P and relatively more mature KLRG-1+ ILC2
cells were respectively identified as LinCD127+Sca-1hiCD25+KLRG-1 and
LinCD127+Sca-1hiCD25+KLRG-1+ cells. Expression of GATA-3 by these
BM ILC2P and ILC2-related cells was verified. The expression of homing
receptors by ILCs and ILC2P was determined using antibodies to
CCR7 (4B12), CCR9 (242503), a4b7 (DATK32), and CD103 (2E7) (Wang
et al., 2010).
Cell Isolation
Lineage-depleted cells (95% pure) were isolated from the spleen by
depleting cells expressing CD3ε, CD5, CD19, B220, CD11b, CD11c, Ter119,
F4/80, and Gr-1 (splenocyte depletion markers) using biotin-labeled anti-
bodies and anti-biotin beads (Miltenyi Biotec) for most experiments that did
not need highly pure ILCs (Figures 3A–3E, 4Aand 4B, 6A and 6B). ILC3 were
FACS-sorted (LinNK1.1KLRG-1CD90hiCD127+; 90% pure based on
RORgt expression) or MACS-sorted (LinNK1.1KLRG-1CD90hi; 87%
pure) by depleting cells expressing above mentioned antigens and NK1.1,and then further depleted of KLRG-1+ cells using PE-conjugated KLRG-1/
anti-PE beads followed by positive selection of CD90+ cells using FITC-conju-
gated CD90.2 antibody/anti-FITC beads. BMcells depleted of cells expressing
the BM lineage markers and Ly-6B.2 (7/4) were prepared by MACS and used
as the source of BM ILC2P for the homing study.
Cell Culture
The spleen lineage-depleted cells or sorted LinNK1.1KLRG-1CD90hi
CD127+ ILC3 were cultured for 4 days in complete RPMI 1640 medium (10%
FBS) supplemented with cecal bacterial extract (10 mg/ml), IL-7 (20 ng/ml), and
IL-23 (20 ng/ml) for ILC3. Spleen Lin cells were also cultured with cecal bac-
terial extract, IL-7 and IL-15 (20 ng/ml) for ILC1 or IL-7 for ILC2. When indi-
cated, RA (10 nM, all-trans RA), Ro41-5253 (500 nM, a RARa antagonist),
AM580 (10 nM, RARa agonist), AC55649 (10 nM, a RARb2 agonist), or
LE540 (500 nM, a pan-RAR antagonist), was used. These chemicals were
from Sigma-Aldrich or Enzo Life Sciences. Cells were harvested on day 4
and stained for CCR7, CCR9, a4b7, and ILC-associated antigens and tran-
scription factors. For DCs and ILC co-culture, CD11c+ cells were isolated
from splenocytes and MLN cells with CD11c microbeads (Miltenyi Biotec) (pu-
rity > 90%). 53 104 spleen andMLN-DCs, pulsed with cecal bacterial extracts
(10 mg/ml) for 3 hr, were co-cultured with 53 105 spleen Lin cells in complete
RPMI medium containing 10% FBS (non-heat inactivated) for 4 days.
Chemotaxis Assay
Spleen Lin cells (5 3 105/well), cultured in the presence or absence of RA
(10 nM) or Ro41-5253 (500 nM) for 4 days, were placed in the upper chamber
of Transwell inserts (Corning) and allowed to migrate to the lower chamber
containing murine CCL25 (3 mg/ml, R&D Systems) for 3 hr. The cells in the
lower chambers were collected, stained with antibodies to identify ILC1,
ILC2, and ILC3, and counted by a time-based flow cytometry (Kim and Brox-
meyer, 1998).
Short-Term Migration of ILCs
Cultured CD45.2+CD90.1+ WT and CD45.2+CD90.2+ homing receptor-defi-
cient spleen Lin cells (10-15 million cells each) were co-injected i.v. into
CD45.1 mice. The host mice were sacrificed 20 hr later, and indicated organs
were harvested. The numbers of injected ILC3 migrated into each organ or in
the blood were determined by flow cytometry. The relative homing index for
homing receptor-deficient ILCs was calculated as below: Homing index of
homing receptor-deficient ILC for organs A = [CD90.2+ homing receptor-
deficient ILCs in organ A] / [CD90.1+ WT ILCs in organ A]O [CD90.2+ homing
receptor-deficient ILCs in injected cells] / [CD90.1+ WT ILCs in injected cells].
Similar experiments were performed for control versus RA-treated ILCs. For
migration of BMKLRG-1/+ ILC2 lineage cells, CD45.2+ LinBMcells, isolated
from WT or homing receptor-deficient BM (35 million cells/mouse), were
singly injected i.v. into CD45.1 mice. The host mice were sacrificed 44 hr later,
and indicated organs were harvested and examined by flow cytometry for
numbers of transferred ILC2 lineage cells in each organ. Migration efficiency
of homing receptor-deficient ILC2P to an organ was determined based on
the normalized absolute numbers of transferred ILC2 lineage cells in each or-
gan that were divided by the total numbers of the transferred ILC2 lineage cells
in indicated organs.
Confocal Microscopy
Ileum tissues were frozen in Tissue-Tek OCT Compound (Sakura) and 9-mm
tissue sections were made using a cryostat (Leica). The sections were fixed
in cold acetone, and stained with fluorochrome-conjugated antibodies to
pan-cytokeratin (Clone AE1/AE3), CD90.2, and CD3 (Clone 17A2) or CD4.
The images were collected with a SP5 II (Leica) confocal microscope.
Long-Term Population of ILCs following Mixed-BM Transplantation
A 1:1 mixture of BM cells (5 3 106 each) from CD45.2+CD90.1+ WT mice and
CD45.2+CD90.2+ homing receptor-deficient mice were co-injected i.v. into
irradiated (2 3 500 cGy with a 3 hr interval) CD45.1 congenic mice. The
mice were sacrificed 8 weeks later for evaluation of ILC1/2/3 frequencies
and numbers in each organ. On average, the marrow reconstitution efficiency
in these animals was greater than 95% based on CD45.2 frequency in the
spleen.Immunity 43, 107–119, July 21, 2015 ª2015 Elsevier Inc. 117
ILC Transfer and Infection with C. rodentium
VADmice were generated as described before (Kang et al., 2009) and injected
i.v. with WT control ILC3, WT RA-ILC3, or homing receptor-deficient RA-ILC3
(92% pure;13 106 cells/mouse) two times on day2 and 2 post-infection
with C. rodentium. Mice were infected with C. rodentium (DBS100, 109 CFU/
mouse) via oral gavage and monitored for weight change, stool consistency,
and C. rodentium load (Kim et al., 2013). Mice were sacrificed on day 9
post-infection.
qRT-PCR
Quantitative real-time PCR (qRT-PCR) was performed as described before
(Kim et al., 2013) to detect mRNA expression for Il22, Il17a, and anti-microbial
peptide genes in SI and proximal colon tissues. The primers used for qRT-PCR
are shown in Table S1.
Statistical Analysis
Student’s t test (paired, two-tailed) was used to determine significance of the
differences between two groups. p values < or = 0.05 were considered
significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and one tables and can be
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